Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · IEX Real-Time Price · USD
2.190
-0.010 (-0.45%)
At close: Apr 25, 2024, 4:00 PM
2.290
+0.100 (4.57%)
After-hours: Apr 25, 2024, 7:54 PM EDT

Lexaria Bioscience Income Statement

Millions USD. Fiscal year is Sep - Aug.
Year 2023202220212020201920182017201620152014 2013 - 2005
Revenue
0.230.260.720.310.220.430.060.040.010
Upgrade
Revenue Growth (YoY)
-11.43%-64.66%129.59%41.41%-48.62%580.85%56.29%176.96%--
Upgrade
Cost of Revenue
0.030.070.180.10.020.030.030.050.030
Upgrade
Gross Profit
0.190.180.550.220.20.410.03-0-0.020
Upgrade
Selling, General & Admin
3.064.964.973.983.646.511.831.221.511.14
Upgrade
Research & Development
3.671.841.260.390.560.490.050.010.150
Upgrade
Other Operating Expenses
00-1.5200.140.010.070.040.280.25
Upgrade
Operating Expenses
6.736.84.714.364.347.021.961.271.931.39
Upgrade
Operating Income
-6.53-6.62-4.16-4.15-4.14-6.61-1.92-1.27-1.95-1.39
Upgrade
Interest Expense / Income
0000000.0100.030.17
Upgrade
Other Expense / Income
0.180.760.02-0.060.02-0.060.06-0.051.7
Upgrade
Pretax Income
-6.71-7.38-4.19-4.08-4.16-6.61-1.99-1.34-1.93-3.25
Upgrade
Income Tax
0000000000.01
Upgrade
Net Income
-6.71-7.38-4.19-4.08-4.16-6.61-1.99-1.34-1.93-3.26
Upgrade
Preferred Dividends
-0.05-0.11-0.16-0.15-0.06-0.01-0.12-0.12-0.160
Upgrade
Net Income Common
-6.66-7.27-4.03-3.93-4.1-6.6-1.87-1.21-1.77-3.26
Upgrade
Shares Outstanding (Basic)
7643322111
Upgrade
Shares Outstanding (Diluted)
7643322111
Upgrade
Shares Change
12.38%34.02%58.34%6.95%9.63%20.75%34.04%10.43%54.44%42.23%
Upgrade
EPS (Basic)
-1.01-1.24-0.95-1.47-1.50-2.70-0.90-0.90-1.20-3.82
Upgrade
EPS (Diluted)
-1.01-1.24-0.95-1.47-1.50-2.70-0.90-0.90-1.20-3.82
Upgrade
Free Cash Flow
-5.91-4.93-3.99-2.62-3.65-2.52-1.55-0.66-0.78-0.58
Upgrade
Free Cash Flow Per Share
-0.89-0.84-0.91-0.94-1.41-1.06-0.79-0.45-0.59-0.68
Upgrade
Gross Margin
86.07%71.87%75.74%68.43%89.72%94.19%53.25%-12.03%-103.26%-
Upgrade
Operating Margin
-2888.50%-2591.67%-576.16%-1317.94%-1860.64%-1525.36%-3022.44%-3131.29%-13250.90%-
Upgrade
Profit Margin
-2946.36%-2846.28%-557.19%-1249.71%-1841.53%-1522.97%-2937.31%-2983.38%-12042.58%-
Upgrade
Free Cash Flow Margin
-2614.84%-1929.75%-552.02%-831.91%-1640.42%-581.13%-2429.18%-1630.61%-5300.10%-
Upgrade
EBITDA
-6.52-7.24-4.03-3.93-4.1-6.61-1.98-1.34-1.9-2.93
Upgrade
EBITDA Margin
-2883.78%-2833.68%-557.69%-1248.08%-1840.83%-1524.83%-3114.68%-3283.21%-12918.17%-
Upgrade
Depreciation & Amortization
0.190.150.160.160.0600000.16
Upgrade
EBIT
-6.71-7.38-4.19-4.08-4.16-6.61-1.98-1.34-1.9-3.09
Upgrade
EBIT Margin
-2967.41%-2891.05%-579.21%-1297.56%-1868.03%-1525.36%-3117.02%-3284.73%-12918.17%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).